Aquaporin 5 expression in mouse mammary gland cells is not driven by promoter methylation

BioMed Research International
Barbara ArbeithuberIrene Tiemann-Boege

Abstract

Several studies have revealed that aquaporins play a role in tumor progression and invasion. In breast carcinomas, high levels of aquaporin 5 (AQP5), a membrane protein involved in water transport, have been linked to increased cell proliferation and migration, thus facilitating tumor progression. Despite the potential role of AQP5 in mammary oncogenesis, the mechanisms controlling mammary AQP5 expression are poorly understood. In other tissues, AQP5 expression has been correlated with its promoter methylation, yet, very little is known about AQP5 promoter methylation in the mammary gland. In this work, we used the mouse mammary gland cell line EpH4, in which we controlled AQP5 expression via the steroid hormone dexamethasone (Dex) to further investigate mechanisms regulating AQP5 expression. In this system, we observed a rapid drop of AQP5 mRNA levels with a delay of several hours in AQP5 protein, suggesting transcriptional control of AQP5 levels. Yet, AQP5 expression was independent of its promoter methylation, or to the presence of negative glucocorticoid receptor elements (nGREs) in its imminent promoter region, but was rather influenced by the cell proliferative state or cell density. We conclude that AQP5 promoter methyla...Continue Reading

References

Aug 11, 1997·Gene·S J ClarkP L Molloy
May 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·I ZucchiR Dulbecco
Apr 22, 2003·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Jonathan M ShillingfordLothar Hennighausen
Mar 24, 2004·Trends in Endocrinology and Metabolism : TEM·Christian J GruberJohannes C Huber
Sep 2, 2004·Nature Reviews. Molecular Cell Biology·Landon S KingPeter Agre
Apr 22, 2005·Histochemistry and Cell Biology·Toshiyuki MatsuzakiKuniaki Takata
Jun 25, 2005·Seminars in Cancer Biology·Hynda K Kleinman, George R Martin
Jul 5, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jie Hu, A S Verkman
Sep 1, 2006·Biochemical and Biophysical Research Communications·Susanne Wurm, Christian Wechselberger
Jan 3, 2007·Biochemical and Biophysical Research Communications·Johji NomuraYoichiro Isohama
May 22, 2007·The Journal of Nutrition·Yi Wang, Emad Tajkhorshid
Jul 17, 2007·Biochemical and Biophysical Research Communications·Helene MörwaldChristian Wechselberger
Feb 19, 2008·Respiratory Physiology & Neurobiology·Yong BenChunxue Bai
Jun 28, 2008·The American Journal of Pathology·Sung Koo KangChulso Moon
Oct 1, 2009·Nature Reviews. Genetics·Peter A Jones, Gangning Liang
May 11, 2010·The Journal of Pathology·Ziqiang ZhangChunxue Bai
Aug 5, 2010·Nature Reviews. Molecular Cell Biology·Susan C Wu, Yi Zhang

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
Flow
fluorescence activated cell sorting
PCR
Transfection
restriction digests
transfections
Assay
FCS
FACS
biopsies

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Journal of Mammary Gland Biology and Neoplasia
Ali Mobasheri, Richard Barrett-Jolley
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Julia FredeMustafa B A Djamgoz
© 2021 Meta ULC. All rights reserved